LINC00511 and carcinoma: LINC00511 overexpression is prevalent in a wide range of carcinomas and is responsible for advanced disease stage, tumour growth, lymph node metastasis, poor prognosis, a disappointing overall survival rate, and an elevated rate of relapse [26].